Life Science Nation Newsletter  |  May 7, 2015  |  Issue 110

  The LSN Story   |   Investor Platform   |   Company Platform   |   RESI Conference   |   Fundraising Accelerator
Life Science Investor Mandates (Apr. 30 - May. 6)

Seeking Range of Therapeutics Opportunities Globally

Seeking 510k Devices in Eastern US

Looking for Therapeutics and Companion Diagnostics
Looking for Early Stage Single Use Delivery Devices
In This Issue

New Models Emerge to Aid Scientist-Entrepreneurs Journey from Bench to Bedside

RESI @ TMCx Panel Agenda Finalized: Life Science Luminaries Share Their Expertise Through 16 Panels

Partnering Launches Tomorrow, Get Your Meetings Before It's Too Late!

  READ MORE

RESI @ TMCx Sponsors
RESI Conference Group's Upcoming Events
LSN Videos
RESI 4 Recap Video, San Francisco, 2015
RESI 4 Investor Panel Videos
 Fundraising Boot Camp
New Models Emerge to Aid Scientist-Entrepreneurs Journey from Bench to Bedside: Privatized R&D, Studios, Incubators, Accelerators, and New Early Stage VC/PE Funds
By Michael Quigley, Director of Research, LSN

Developing and commercializing a product in the life science space is notoriously capital intensive and usually involves a high level of risk. To assist with this difficult development process, many organizations have formed that are designing and utilizing new approaches to help move science forward in the early stages of development and clinical research. These include Studios, Incubators, Accelerators, and Funds that aim to create more financially efficient and de-risked models of engagement for companies and investors. The RESI conference will bring together some of the best and brightest of these groups to discuss how they are creating, coaching, and funding life science companies in a more productive manner. 

 

During this panel, moderated by Dennis Ford, CEO & founder of Life Science Nation, the audience will hear from:

  • Melinda Richter, Head, Johnson & Johnson Innovation, JLABS
  • Bill McKeon, EVP, CSO, & COO, Texas Medical Center
  • Lisa Rhoads, Managing Director, Easton Capital
  • David Lucchino, Entrepreneur In Residence, Puretech
  • Leo Linbeck, III, Chairman & Founder, Fannin Innovation Studio 

Although the forming of virtual companies has shown great promise in reducing costs and keeping companies nimble, along the product development pathway, many inefficiencies remain. This panel will discuss what some of the most cutting-edge groups in the space are doing to tackle these challenges. Conference attendees are sure to gain insight from these individuals who are working to make the life science product development process more streamlined. 

 READ MORE

RESI @ TMCx Panel Agenda Finalized: Life Science Luminaries Share Their Expertise Through 16 Panels 

By Lucy Parkinson, Senior Research Manager, LSN 

 

The RESI @ TMCx morning session will offer separate biotech and medtech panels, featuring angels, family offices, and major healthcare corporations that work with startups in these areas. In the afternoon, RESI's panels will be more topical, with two sessions devoted to new funding alternatives in life science - venture philanthropy and emerging development models - and six sessions focused on fundraising . Finally, in the Tales from the Road session, the audience will hear from start-up CEOs about their recent experiences in raising money to grow their companies.

 

The RESI @ TMCx morning session will offer separate biotech and medtech panels, featuring angels, family offices, and major healthcare corporations that work with startups in these areas. In the afternoon, RESI's panels will be more topical, with two sessions devoted to new funding alternatives in life science - venture philanthropy and emerging development models - and six sessions focused on fundraising in major life sectors: oncology, cardiology, neurology, healthcare IT, and the Internet of medtech. Finally, in the Tales from the Road session, the audience will hear from start-up CEOs about their recent experiences in raising money to grow their companies...

 

Partnering Launches Tomorrow, Get Your Meetings Before It's Too Late!

By Alejandro Zamorano, VP of Business Development, LSN 

 

Tomorrow the partnering platform for RESI @ TMCx goes live, making scheduling a meeting with relevant companies and investors just a few clicks away.

 

The sheer quantity and diversity of investors attending RESI, paired with the power of the RESI Partnering Platform, makes the RESI conference the place for early stage life science companies to meet investors that are a fit.

 

LSN has partnered with Meeting Mojo, an emerging partnering portal developer based in the UK. RESI attendees can use the system to find other attendees who are a fit for their product, development stage, and other relevant factors.  This highly customized solution uses metatagged profiles populated by LSNs propitiatory investor data that can be searched by the scientist entrepreneur attendees to pinpoint a specific fit for an investment mandate by one of the investment firms present at RESI. The RESI Partnering Platform provides the foundation for a one-of-a-kind partnering experience based on current investor mandates that can be easily matched to the emerging biotech and medtech startups that fit the investment criteria...

 

 READ MORE

 

RESI Partnering Platform Video Tutorial